Header Logo

Connection

YOSHIO YAMAOKA to Stomach Neoplasms

Back to Details
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Stomach Neoplasms.
YOSHIO YAMAOKA
Connection Strength
17.654
Stomach Neoplasms
  1. Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer. Helicobacter. 2025 Mar-Apr; 30(2):e70022.
    View in: PubMed
    Score: 0.595
  2. Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during Helicobacter pylori Infection. Gut Liver. 2024 01 15; 18(1):60-69.
    View in: PubMed
    Score: 0.538
  3. Comparative genomics of two Vietnamese Helicobacter pylori strains, CHC155 from a non-cardia gastric cancer patient and VN1291 from a duodenal ulcer patient. Sci Rep. 2023 05 31; 13(1):8869.
    View in: PubMed
    Score: 0.527
  4. The interaction between autophagy, Helicobacter pylori, and gut microbiota in gastric carcinogenesis. Trends Microbiol. 2023 10; 31(10):1024-1043.
    View in: PubMed
    Score: 0.523
  5. Low-grade intestinal metaplasia in Indonesia: Insights into the expression of proinflammatory cytokines during Helicobacter pylori infection and unique East-Asian CagA characteristics. Cytokine. 2023 03; 163:156122.
    View in: PubMed
    Score: 0.513
  6. Genome-wide association study of gastric cancer- and duodenal ulcer-derived Helicobacter pylori strains reveals discriminatory genetic variations and novel oncoprotein candidates. Microb Genom. 2021 11; 7(11).
    View in: PubMed
    Score: 0.472
  7. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One. 2021; 16(8):e0255601.
    View in: PubMed
    Score: 0.465
  8. Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay. J Gastroenterol Hepatol. 2021 Aug; 36(8):2198-2209.
    View in: PubMed
    Score: 0.452
  9. Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity. Int J Mol Sci. 2020 Oct 08; 21(19).
    View in: PubMed
    Score: 0.439
  10. Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma. Toxins (Basel). 2020 08 29; 12(9).
    View in: PubMed
    Score: 0.435
  11. Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply. Aliment Pharmacol Ther. 2020 06; 51(12):1447-1449.
    View in: PubMed
    Score: 0.428
  12. Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis. World J Gastroenterol. 2020 Apr 21; 26(15):1820-1840.
    View in: PubMed
    Score: 0.425
  13. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. PLoS One. 2020; 15(4):e0230064.
    View in: PubMed
    Score: 0.424
  14. Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Aliment Pharmacol Ther. 2020 04; 51(8):770-780.
    View in: PubMed
    Score: 0.421
  15. Analysis of risks of gastric cancer by gastric mucosa among Indonesian ethnic groups. PLoS One. 2019; 14(5):e0216670.
    View in: PubMed
    Score: 0.398
  16. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci. 2018 Aug 16; 19(8).
    View in: PubMed
    Score: 0.378
  17. How to eliminate gastric cancer-related death worldwide? Nat Rev Clin Oncol. 2018 07; 15(7):407-408.
    View in: PubMed
    Score: 0.375
  18. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. Gastric Cancer. 2019 01; 22(1):104-112.
    View in: PubMed
    Score: 0.374
  19. New observations regarding Helicobacter pylori and gastric cancer in Mongolia. Helicobacter. 2018 Aug; 23(4):e12491.
    View in: PubMed
    Score: 0.373
  20. Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand. PLoS One. 2017; 12(10):e0187113.
    View in: PubMed
    Score: 0.358
  21. Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. J Dig Dis. 2016 Jan; 17(1):20-7.
    View in: PubMed
    Score: 0.315
  22. RAD51 G135C genetic polymorphism and their potential role in gastric cancer induced by Helicobacter pylori infection in Bhutan. Epidemiol Infect. 2016 Jan; 144(2):234-40.
    View in: PubMed
    Score: 0.304
  23. The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence. Biomed Res Int. 2015; 2015:830813.
    View in: PubMed
    Score: 0.302
  24. [A case of gastric cancer accompanied by disseminated carcinomatosis of bone marrow wherein long-term chemotherapy was enabled by early supportive palliative care]. Gan To Kagaku Ryoho. 2014 Feb; 41(2):257-9.
    View in: PubMed
    Score: 0.276
  25. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Biomark Med. 2014; 8(9):1127-37.
    View in: PubMed
    Score: 0.274
  26. Intact long-type dupA as a marker for gastroduodenal diseases in Okinawan subpopulation, Japan. Helicobacter. 2013 Feb; 18(1):66-72.
    View in: PubMed
    Score: 0.250
  27. Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan. BMC Gastroenterol. 2011 Dec 22; 11:141.
    View in: PubMed
    Score: 0.238
  28. Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J Clin Microbiol. 2012 Feb; 50(2):441-8.
    View in: PubMed
    Score: 0.237
  29. Virulence factors or ancestral origin of Helicobacter pylori: which is a better predictor of gastric cancer risk? Gut. 2012 Mar; 61(3):469-70.
    View in: PubMed
    Score: 0.229
  30. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol. 2010 Dec; 5(12):1885-93.
    View in: PubMed
    Score: 0.222
  31. Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol. 2010 Apr; 4(2):149-56.
    View in: PubMed
    Score: 0.212
  32. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009 Oct; 47(10):3241-5.
    View in: PubMed
    Score: 0.203
  33. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009 May; 10(2):77-84.
    View in: PubMed
    Score: 0.199
  34. The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect. 2009 Sep; 15(9):835-42.
    View in: PubMed
    Score: 0.198
  35. Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15; 877(11-12):1193-9.
    View in: PubMed
    Score: 0.197
  36. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 2008; 47(12):1077-83.
    View in: PubMed
    Score: 0.187
  37. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 2006 May 15; 66(10):5111-20.
    View in: PubMed
    Score: 0.162
  38. Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II. Gut. 2025 Oct 08; 74(11):1767-1791.
    View in: PubMed
    Score: 0.155
  39. Fine-scale population structure of Japanese Helicobacter pylori provides new anthropological and epidemiological insights. Microb Genom. 2025 Jun; 11(6).
    View in: PubMed
    Score: 0.151
  40. The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. Dig Dis Sci. 2004 Sep; 49(9):1551-5.
    View in: PubMed
    Score: 0.144
  41. Simultaneous detection of Helicobacter pylori infection comparing between white light and image-enhanced endoscopy. BMC Gastroenterol. 2024 Jan 26; 24(1):46.
    View in: PubMed
    Score: 0.138
  42. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial). PLoS One. 2023; 18(9):e0291926.
    View in: PubMed
    Score: 0.135
  43. A single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development. Cell Host Microbe. 2023 08 09; 31(8):1345-1358.e6.
    View in: PubMed
    Score: 0.133
  44. A comprehensive evaluation of an animal model for Helicobacter pylori-associated stomach cancer: Fact and controversy. Helicobacter. 2023 Feb; 28(1):e12943.
    View in: PubMed
    Score: 0.128
  45. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol. 2002 Sep; 97(9):2231-8.
    View in: PubMed
    Score: 0.125
  46. Genomic differentiation within East Asian Helicobacter pylori. Microb Genom. 2022 02; 8(2).
    View in: PubMed
    Score: 0.120
  47. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr. 2022 01 03; 41(1):2.
    View in: PubMed
    Score: 0.119
  48. Gastric epithelial attachment of Helicobacter pylori induces EphA2 and NMHC-IIA receptors for Epstein-Barr virus. Cancer Sci. 2021 Nov; 112(11):4799-4811.
    View in: PubMed
    Score: 0.117
  49. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. 2001 Jun; 6(2):116-24.
    View in: PubMed
    Score: 0.115
  50. A bacterial small RNA regulates the adaptation of Helicobacter pylori to the host environment. Nat Commun. 2021 04 09; 12(1):2085.
    View in: PubMed
    Score: 0.114
  51. Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial). PLoS One. 2020; 15(10):e0239434.
    View in: PubMed
    Score: 0.110
  52. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
    View in: PubMed
    Score: 0.110
  53. Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam. Gut Liver. 2019 09 15; 13(5):483-497.
    View in: PubMed
    Score: 0.102
  54. CagA status and gastric cancer unreliable serological tests produce unreliable data. Gastroenterology. 1999 Sep; 117(3):745.
    View in: PubMed
    Score: 0.102
  55. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999 Mar; 52(3):215-8.
    View in: PubMed
    Score: 0.098
  56. Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years. PLoS One. 2018; 13(5):e0197695.
    View in: PubMed
    Score: 0.093
  57. Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. Toxins (Basel). 2018 04 19; 10(4).
    View in: PubMed
    Score: 0.092
  58. Characterizing Helicobacter pylori cagA in Myanmar. Gut Liver. 2018 Jan 15; 12(1):51-57.
    View in: PubMed
    Score: 0.091
  59. Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh. PLoS One. 2017; 12(8):e0182947.
    View in: PubMed
    Score: 0.088
  60. Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas. PLoS Genet. 2017 02; 13(2):e1006546.
    View in: PubMed
    Score: 0.085
  61. Highly sensitive fluorescence detection of metastatic lymph nodes of gastric cancer with photo-oxidation of protoporphyrin IX. Eur J Surg Oncol. 2016 Aug; 42(8):1236-46.
    View in: PubMed
    Score: 0.080
  62. Geographical distribution of the incidence of gastric cancer in Bhutan. World J Gastroenterol. 2015 Oct 14; 21(38):10883-9.
    View in: PubMed
    Score: 0.078
  63. Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection. World J Gastroenterol. 2015 Jul 21; 21(27):8408-17.
    View in: PubMed
    Score: 0.076
  64. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules. 2015 Apr 08; 20(4):6068-92.
    View in: PubMed
    Score: 0.075
  65. Helicobacter pylori from gastric cancer and duodenal ulcer show same phylogeographic origin in the Andean region in Colombia. PLoS One. 2014; 9(8):e105392.
    View in: PubMed
    Score: 0.072
  66. Genetic battle between Helicobacter pylori and humans. The mechanism underlying homologous recombination in bacteria, which can infect human cells. Microbes Infect. 2014 Oct; 16(10):833-9.
    View in: PubMed
    Score: 0.072
  67. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol. 2014 Jan; 29(1):67-73.
    View in: PubMed
    Score: 0.069
  68. Strategy for the treatment of Helicobacter pylori infection. Curr Pharm Des. 2014; 20(28):4489-500.
    View in: PubMed
    Score: 0.069
  69. Virulence genes of Helicobacter pylori in gastritis, peptic ulcer and gastric cancer in Laos. Asian Pac J Cancer Prev. 2014; 15(20):9027-31.
    View in: PubMed
    Score: 0.069
  70. The significance of virulence factors in Helicobacter pylori. J Dig Dis. 2013 Jul; 14(7):341-9.
    View in: PubMed
    Score: 0.066
  71. Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol. 2013 May 14; 19(18):2806-10.
    View in: PubMed
    Score: 0.066
  72. Helicobacter pylori cagA 12-bp insertion can be a marker for duodenal ulcer in Okinawa, Japan. J Gastroenterol Hepatol. 2013 Feb; 28(2):291-6.
    View in: PubMed
    Score: 0.064
  73. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013 Jan; 7(1):35-40.
    View in: PubMed
    Score: 0.064
  74. Role of renin-angiotensin system in gastric oncogenesis. J Gastroenterol Hepatol. 2012 Mar; 27(3):442-51.
    View in: PubMed
    Score: 0.060
  75. Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS One. 2012; 7(1):e30354.
    View in: PubMed
    Score: 0.060
  76. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol. 2012 Mar; 50(3):876-83.
    View in: PubMed
    Score: 0.060
  77. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol. 2010 Mar 14; 16(10):1188-200.
    View in: PubMed
    Score: 0.053
  78. Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol. 2010 Jan; 25(1):172-7.
    View in: PubMed
    Score: 0.051
  79. The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis. 2009 Oct; 28(10):1227-36.
    View in: PubMed
    Score: 0.050
  80. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp (Warsz). 2009 Jan-Feb; 57(1):45-56.
    View in: PubMed
    Score: 0.049
  81. Helicobacter and gastric malignancies. Helicobacter. 2008 Oct; 13 Suppl 1:28-34.
    View in: PubMed
    Score: 0.048
  82. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. J Infect Dis. 2008 Jun 15; 197(12):1752-61.
    View in: PubMed
    Score: 0.047
  83. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008 Jan 15; 68(2):379-87.
    View in: PubMed
    Score: 0.045
  84. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. Scand J Gastroenterol. 2008 Jan; 43(1):25-33.
    View in: PubMed
    Score: 0.045
  85. Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):49-58.
    View in: PubMed
    Score: 0.042
  86. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun; 55(6):775-81.
    View in: PubMed
    Score: 0.039
  87. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9.
    View in: PubMed
    Score: 0.038
  88. Helicobacter pylori-dependent NF-kappa B activation in newly established Mongolian gerbil gastric cancer cell lines. Cancer Sci. 2005 Mar; 96(3):170-5.
    View in: PubMed
    Score: 0.037
  89. Helicobacter pylori virulence factor CagA promotes Snail-mediated epithelial-mesenchymal transition and invasive behavior by downregulating Semaphorin 5A in gastric epithelial cells. Biochem Biophys Res Commun. 2025 03 01; 750:151421.
    View in: PubMed
    Score: 0.037
  90. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004 Oct; 9(5):453-9.
    View in: PubMed
    Score: 0.036
  91. Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice. Expert Rev Gastroenterol Hepatol. 2024 Aug; 18(8):457-472.
    View in: PubMed
    Score: 0.036
  92. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology. 2004 Apr; 126(4):1030-43.
    View in: PubMed
    Score: 0.035
  93. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol. 2003 Nov; 10(6):1025-8.
    View in: PubMed
    Score: 0.034
  94. Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol. 1999 Oct; 94(10):3034-8.
    View in: PubMed
    Score: 0.026
  95. Variability in the interpretation of microsatellite patterns with different electrophoretic conditions. Mol Pathol. 1999 Oct; 52(5):302-4.
    View in: PubMed
    Score: 0.026
  96. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999 Jul; 37(7):2274-9.
    View in: PubMed
    Score: 0.025
  97. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
    View in: PubMed
    Score: 0.024
  98. Regression of atypical lymphoid hyperplasia after eradication of Helicobacter pylori. J Gastroenterol. 1997 Aug; 32(4):543-7.
    View in: PubMed
    Score: 0.022
  99. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains. BMC Microbiol. 2016 09 02; 16(1):201.
    View in: PubMed
    Score: 0.021
  100. Influence of prostate stem cell antigen gene polymorphisms on susceptibility to Helicobacter pylori-associated diseases: a case-control study. Helicobacter. 2015 Apr; 20(2):106-13.
    View in: PubMed
    Score: 0.018
  101. Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol. 2014 Sep; 63(Pt 9):1189-1196.
    View in: PubMed
    Score: 0.018
  102. A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One. 2009 Nov 06; 4(11):e7736.
    View in: PubMed
    Score: 0.013
  103. Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol. 2009 Aug; 24(8):1380-6.
    View in: PubMed
    Score: 0.013
  104. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem. 2009 Jan 16; 284(3):1612-9.
    View in: PubMed
    Score: 0.012
  105. vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis. 2008 Jul; 61(4):290-3.
    View in: PubMed
    Score: 0.012
  106. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res. 2006 May 15; 12(10):3216-21.
    View in: PubMed
    Score: 0.010
  107. Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol. 2004 Apr; 42(4):1648-51.
    View in: PubMed
    Score: 0.009
  108. Helicobacter pylori. Med Clin North Am. 2000 Sep; 84(5):1125-36, viii.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.